117 related articles for article (PubMed ID: 12070257)
1. Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies.
Scotet V; De Braekeleer M; Audrézet MP; Quéré I; Mercier B; Duguépéroux I; Andrieux J; Blayau M; Férec C
J Med Genet; 2002 Jun; 39(6):443-8. PubMed ID: 12070257
[No Abstract] [Full Text] [Related]
2. [Towards an improved antenatal screening for cystic fibrosis].
Serre JL; Feingold J; Simon-Bouy B; Muller F
Rev Epidemiol Sante Publique; 2003 Apr; 51(2):245-53. PubMed ID: 12876510
[TBL] [Abstract][Full Text] [Related]
3. Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation.
Ogino S; Wilson RB; Grody WW
J Med Genet; 2004 May; 41(5):e70. PubMed ID: 15121798
[No Abstract] [Full Text] [Related]
4. Focus on cystic fibrosis and other disorders evidenced in fetuses with sonographic finding of echogenic bowel: 16-year report from Brittany, France.
Scotet V; Duguépéroux I; Audrézet MP; Audebert-Bellanger S; Muller M; Blayau M; Férec C
Am J Obstet Gynecol; 2010 Dec; 203(6):592.e1-6. PubMed ID: 20932506
[TBL] [Abstract][Full Text] [Related]
5. Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.
Muller F; Dommergues M; Simon-Bouy B; Ferec C; Oury JF; Aubry MC; Bessis R; Vuillard E; Denamur E; Bienvenu T; Serre JL
J Med Genet; 1998 Aug; 35(8):657-60. PubMed ID: 9719372
[TBL] [Abstract][Full Text] [Related]
6. [Hyperechogenic fetal bowel as a marker of fetal cystic fibrosis].
Sukupová M; Dhaifalah I; Adamík Z; Havalová J
Ceska Gynekol; 2015 Jan; 80(1):20-4. PubMed ID: 25723074
[TBL] [Abstract][Full Text] [Related]
7. Analysis of CFTR mutation screening in cases of isolated fetal echogenic bowel in the South Australian population.
Nicholls CM; Nelson PV; Poplawski NK; Chin SJ; Fong BA; Solly PB; Fietz MJ; Fletcher JM
Prenat Diagn; 2003 Dec; 23(12):1023-5. PubMed ID: 14663844
[No Abstract] [Full Text] [Related]
8. Predicting the risk of cystic fibrosis with echogenic fetal bowel and one cystic fibrosis mutation.
Bosco AF; Norton ME; Lieberman E
Obstet Gynecol; 1999 Dec; 94(6):1020-3. PubMed ID: 10576193
[TBL] [Abstract][Full Text] [Related]
9. Female cystic fibrosis mutation carriers and assisted reproductive technology: does carrier status affect reproductive outcomes?
VanWort TA; Lee JA; Karvir H; Whitehouse MC; Beim PY; Copperman AB
Fertil Steril; 2014 Nov; 102(5):1324-30. PubMed ID: 25217870
[TBL] [Abstract][Full Text] [Related]
10. Mid-trimester hyperechogenic bowel in a fetus of Japanese origin: caution in interpreting reported CFTR mutation (L548Q).
Turner CL; Skinner AC; Castle BM; Wellesley DG
Prenat Diagn; 2006 Sep; 26(9):875-6. PubMed ID: 16941515
[No Abstract] [Full Text] [Related]
11. Hyperechogenic bowel loops and meconium ileus in a fetus carrying the D1152H and G542X cystic fibrosis CFTR mutations.
Orgad S; Berkenstadt M; Achiron R; Yahav Y; Gazit E; Barkai G; Loewenthal R
Prenat Diagn; 2002 Jul; 22(7):636-7. PubMed ID: 12124706
[No Abstract] [Full Text] [Related]
12. Carrier screening for cystic fibrosis.
Dungan JS
Obstet Gynecol Clin North Am; 2010 Mar; 37(1):47-59, Table of Contents. PubMed ID: 20494257
[TBL] [Abstract][Full Text] [Related]
13. Mid-trimester hyperechogenic bowel in a fetus of Japanese origin carrying a new mutation of CFTR gene (L548Q).
Yamamoto M; Molina-Gomes D; Girodon-Boulandet E; Moulis M; Leroy B; Simon-Bouy B; Selva J; Ville Y
Prenat Diagn; 2006 Jan; 26(1):6-8. PubMed ID: 16378323
[TBL] [Abstract][Full Text] [Related]
14. Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.
Scotet V; Audrézet MP; Roussey M; Rault G; Blayau M; De Braekeleer M; Férec C
Hum Genet; 2003 Aug; 113(3):280-5. PubMed ID: 12768409
[TBL] [Abstract][Full Text] [Related]
15. Hyperechogenic fetal bowel: counseling difficulties.
Marcus-Soekarman D; Offermans J; Van den Ouweland AM; Mulder AL; Muntjewerff N; Vossen M; Kleijer W; Schrander-Stumpel C; Dooijes D
Eur J Med Genet; 2005; 48(4):421-5. PubMed ID: 16378926
[TBL] [Abstract][Full Text] [Related]
16. Prenatal screening for cystic fibrosis: where are we now?
Farrell PM; Fost N
J Pediatr; 2002 Dec; 141(6):758-63. PubMed ID: 12461490
[No Abstract] [Full Text] [Related]
17. Prenatal screening for cystic fibrosis: an early report card.
Palomaki GE
Genet Med; 2004; 6(3):115-6. PubMed ID: 15354327
[No Abstract] [Full Text] [Related]
18. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
[TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of cystic fibrosis with abnormal ultrasound signs of fetal bowel: results of a French molecular collaborative study based on 641 prospective cases.
Muller F; Simon-Bouy B; Girodon E; Monnier N; Malinge MC; Serre JL;
Am J Med Genet; 2002 Jun; 110(2):109-15. PubMed ID: 12116247
[TBL] [Abstract][Full Text] [Related]
20. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960.
Scotet V; Gillet D; Duguépéroux I; Audrézet MP; Bellis G; Garnier B; Roussey M; Rault G; Parent P; De Braekeleer M; Férec C;
Hum Genet; 2002 Sep; 111(3):247-54. PubMed ID: 12215837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
